All matured mainstream tech stocks are always overvalued. When someone buys into tech they are buying into its future potential. That includes its future stock value. It is extremely overbought during its initial IPO inception into the stock market destined to never again reach a true value status based on 'hope hype' wrapped around the 'you never know' and existing only through the constant embrace of the potential idea that allows them to drink the 'Kool-Aid' that ...
$Apexigen(APGN.US$
在Pyxis Oncology(辉瑞的支持公司)大约 “2023年年中” 收购之前,Apexigen永远不会达到预期的9.00美元高点。Apexxigen已经在裁员,那些留下来并被认为必须留任的人已经签署了激励合同,这些合同将向他们提供每股2.65美元的行使收购价格,到期日最远的将来是2032年。为了让这笔交易提前使Pyxis Oncology受益,这笔交易将...
在Pyxis Oncology(辉瑞的支持公司)大约 “2023年年中” 收购之前,Apexigen永远不会达到预期的9.00美元高点。Apexxigen已经在裁员,那些留下来并被认为必须留任的人已经签署了激励合同,这些合同将向他们提供每股2.65美元的行使收购价格,到期日最远的将来是2032年。为了让这笔交易提前使Pyxis Oncology受益,这笔交易将...
已翻译
First choice: The Good Book ☝️😉 (Helps me find my Spiritual moat)
Second choice: The Little Book That Still Beats the Market by Joel Greenblatt (Helps me find good, low priced valued companies with great potential for growdth and strong moat)
Second choice: The Little Book That Still Beats the Market by Joel Greenblatt (Helps me find good, low priced valued companies with great potential for growdth and strong moat)
$Verb Technology(VERB.US$限价卖单@0.58。不喜欢追逐。耐心是我的朋友。
已翻译
16
6